Mostrar el registro sencillo del ítem
The osteocyte: A multifunctional cell within the bone
dc.contributor.author | Tresguerres F.G.F. | |
dc.contributor.author | Torres J. | |
dc.contributor.author | López-Quiles J. | |
dc.contributor.author | Hernández G. | |
dc.contributor.author | Vega J.A. | |
dc.contributor.author | Tresguerres I.F. | |
dc.date.accessioned | 2020-09-02T22:29:24Z | |
dc.date.available | 2020-09-02T22:29:24Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.1016/j.aanat.2019.151422 | |
dc.identifier.citation | 227, , - | |
dc.identifier.issn | 09409602 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/6440 | |
dc.description | The knowledge of bone biology has largely changed in the last few decades. Osteocytes are multifunctional bone cells that are surrounded by mineralized bone matrix and for decades it was considered that they might be relatively inactive cells. However, nowadays it is known that osteocytes are highly active cells which are indispensable for the normal function of the skeleton, playing main roles in several physiological processes, both within and beyond the bone microenvironment. This review highlights and updates the current state of knowledge of the osteocyte and focuses on its roles in bone remodeling and mineral homeostasis, and also reviews its recently discovered endocrine function. Osteocytes secrete sclerostin (a protein that works as a negative regulator of bone mass), and FGF-23, the most important osteocyte-secreted endocrine factor, since it is able to regulate the phosphate metabolism. Moreover, osteocytes can act as mechanosensory cells, transforming the mechanical strain into chemical signaling towards the effector cells (osteoblasts and osteoclasts). Therefore, the osteocyte plays an important role in bone biology, specifically in the remodeling process, since it regulates both the osteoblast and osteoclast activity. Finally, the paper discusses the clinical application of the bone biology, updating the new therapies against bone-loss disorders. © 2019 Elsevier GmbH | |
dc.language.iso | en | |
dc.publisher | Elsevier GmbH | |
dc.subject | Bone remodeling | |
dc.subject | FGF-23 | |
dc.subject | Osteocyte | |
dc.subject | Sclerostin | |
dc.subject | beta catenin | |
dc.subject | bisphosphonic acid derivative | |
dc.subject | blosozumab | |
dc.subject | calcium | |
dc.subject | cell marker | |
dc.subject | connexin 43 | |
dc.subject | denosumab | |
dc.subject | dickkopf 1 protein | |
dc.subject | fibroblast growth factor 23 | |
dc.subject | glycogen synthase kinase 3 | |
dc.subject | Hermes antigen | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | low density lipoprotein receptor related protein 5 | |
dc.subject | low density lipoprotein receptor related protein 6 | |
dc.subject | matrix metalloproteinase 14 | |
dc.subject | osteocalcin | |
dc.subject | osteoclast differentiation factor | |
dc.subject | osteoprotegerin | |
dc.subject | parathyroid hormone | |
dc.subject | parathyroid hormone receptor 1 | |
dc.subject | parathyroid hormone related protein | |
dc.subject | parathyroid hormone[1-34] | |
dc.subject | phosphate | |
dc.subject | prostaglandin E2 | |
dc.subject | protein E11 | |
dc.subject | receptor activator of nuclear factor kappa B | |
dc.subject | romosozumab | |
dc.subject | sclerostin | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | Wnt protein | |
dc.subject | calcium | |
dc.subject | aging | |
dc.subject | apoptosis | |
dc.subject | atypical femur fracture | |
dc.subject | atypical subtrochanteric femur fracture | |
dc.subject | autocrine effect | |
dc.subject | autophagy | |
dc.subject | bone age | |
dc.subject | bone density | |
dc.subject | bone disease | |
dc.subject | bone fragility | |
dc.subject | bone linning cell | |
dc.subject | bone loss disorder | |
dc.subject | bone marrow cell | |
dc.subject | bone mass | |
dc.subject | bone matrix | |
dc.subject | bone mineralization | |
dc.subject | bone multicellular unit | |
dc.subject | bone necrosis | |
dc.subject | bone remodeling | |
dc.subject | bone structure | |
dc.subject | bone tissue | |
dc.subject | bone tumor | |
dc.subject | bone turnover | |
dc.subject | calcium blood level | |
dc.subject | calcium transport | |
dc.subject | cancer prevention | |
dc.subject | cell activity | |
dc.subject | cell body | |
dc.subject | cell communication | |
dc.subject | cell damage | |
dc.subject | cell death | |
dc.subject | cell differentiation | |
dc.subject | cell function | |
dc.subject | cell maturation | |
dc.subject | cell stimulation | |
dc.subject | cell surface | |
dc.subject | cell transformation | |
dc.subject | cell viability | |
dc.subject | cells by body anatomy | |
dc.subject | cellular distribution | |
dc.subject | cellular secretion | |
dc.subject | chronic kidney disease mineral bone disorder | |
dc.subject | chronic kidney failure | |
dc.subject | cortical bone | |
dc.subject | drug activity | |
dc.subject | effector cell | |
dc.subject | endocrine cell | |
dc.subject | enzyme inhibition | |
dc.subject | extracellular matrix | |
dc.subject | femur fracture | |
dc.subject | femur subtrochanteric fracture | |
dc.subject | fracture nonunion | |
dc.subject | gap junction | |
dc.subject | gene | |
dc.subject | gene expression | |
dc.subject | genetic transcription | |
dc.subject | human | |
dc.subject | incidence | |
dc.subject | ischemia | |
dc.subject | jaw osteonecrosis | |
dc.subject | lacunocanalicular system | |
dc.subject | mechanosensory cell | |
dc.subject | mechanotransduction | |
dc.subject | mesenchymal stem cell | |
dc.subject | microenvironment | |
dc.subject | mineral metabolism | |
dc.subject | nonhuman | |
dc.subject | ossification | |
dc.subject | osteoblast | |
dc.subject | osteoclast | |
dc.subject | osteoclastogenesis | |
dc.subject | osteocyte | |
dc.subject | osteoid | |
dc.subject | osteolysis | |
dc.subject | osteoporosis | |
dc.subject | paracrine signaling | |
dc.subject | pathologic fracture | |
dc.subject | pathophysiology | |
dc.subject | phosphate metabolism | |
dc.subject | porosity | |
dc.subject | postmenopause osteoporosis | |
dc.subject | prophylaxis | |
dc.subject | protein degradation | |
dc.subject | protein expression | |
dc.subject | protein function | |
dc.subject | protein localization | |
dc.subject | protein phosphorylation | |
dc.subject | protein protein interaction | |
dc.subject | protein secretion | |
dc.subject | protein synthesis | |
dc.subject | protein transport | |
dc.subject | regulatory mechanism | |
dc.subject | Review | |
dc.subject | SOST gene | |
dc.subject | trabecular bone | |
dc.subject | trabecular microcrack | |
dc.subject | treatment duration | |
dc.subject | blood | |
dc.subject | bone | |
dc.subject | bone development | |
dc.subject | cytology | |
dc.subject | mechanoreceptor | |
dc.subject | osteocyte | |
dc.subject | physiology | |
dc.subject | Apoptosis | |
dc.subject | Bone and Bones | |
dc.subject | Bone Remodeling | |
dc.subject | Bone Resorption | |
dc.subject | Calcium | |
dc.subject | Endocrine Cells | |
dc.subject | Humans | |
dc.subject | Mechanoreceptors | |
dc.subject | Mechanotransduction, Cellular | |
dc.subject | Osteocytes | |
dc.subject | Osteogenesis | |
dc.title | The osteocyte: A multifunctional cell within the bone | |
dc.type | Review |